Natural bioactive compounds in Alzheimer's disease: From the perspective of type 3 diabetes mellitus

There is a close relationship between Alzheimer's disease (AD) and diabetes mellitus (DM), and the link between the two is often referred to as type 3 diabetes mellitus (T3DM). Many natural bioactive compounds have shown the potential to treat AD and diabetes. We mainly review the polyphenols represented by resveratrol (RES) and proanthocyanidins (PCs) and alkaloids represented by berberine (BBR) and Dendrobium nobile Lindl. alkaloids (DNLA) from the perspective of T3DM to review the neuroprotective effects and molecular mechanisms of natural compounds in AD.

[1]  T. Lancet.  Lecanemab for Alzheimer's disease: tempering hype and hope , 2022, The Lancet.

[2]  B. Imbimbo,et al.  Role of monomeric amyloid-β in cognitive performance in Alzheimer's disease:insights from clinical trials with secretase inhibitors and monoclonal antibodies. , 2022, Pharmacological research.

[3]  S. Tolu,et al.  Type 2 Diabetes Mellitus and Alzheimer’s Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets , 2022, International journal of molecular sciences.

[4]  Yuan Zhang,et al.  Bromo-protopine, a novel protopine derivative, alleviates tau pathology by activating chaperone-mediated autophagy for Alzheimer’s disease therapy , 2022, Frontiers in Molecular Biosciences.

[5]  P. Reddy,et al.  Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies , 2022, International journal of molecular sciences.

[6]  A. Bera,et al.  Reduction of kinesin I heavy chain decreases tau hyperphosphorylation, aggregation, and memory impairment in Alzheimer’s disease and tauopathy models , 2022, Frontiers in Molecular Biosciences.

[7]  K. Cheung,et al.  Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies , 2022, Journal of Biomedical Science.

[8]  S. Sourdet,et al.  Nutrients and amyloid β status in the brain: A narrative review , 2022, Ageing Research Reviews.

[9]  Jorge E. Wong-Paz,et al.  Procyanidins: From Agro-Industrial Waste to Food as Bioactive Molecules , 2021, Foods.

[10]  S. Senapati,et al.  Protopine promotes the proteasomal degradation of pathological tau in Alzheimer's disease models via HDAC6 inhibition. , 2021, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[11]  Chen Wang,et al.  SOCS1 Mediates Berberine-Induced Amelioration of Microglial Activated States in N9 Microglia Exposed to β Amyloid , 2021, BioMed research international.

[12]  M. Akash,et al.  Neuroprotective potential of berberine in modulating Alzheimer's disease via multiple signaling pathways. , 2021, Journal of food biochemistry.

[13]  K. Rajaram,et al.  Alzheimer's Disease and other Tauopathies: Exploring Efficacy of Medicinal Plant-Derived Compounds in Alleviating Tau-Mediated Neurodegeneration. , 2021, Current molecular pharmacology.

[14]  Jingshan Shi,et al.  Protective Effects and Mechanisms of Dendrobium nobile Lindl. Alkaloids on PC12 Cell Damage Induced by Aβ25-35 , 2021, Behavioural neurology.

[15]  M. R. França,et al.  Metformin prevents p-tau and amyloid plaque deposition and memory impairment in diabetic mice , 2021, Experimental Brain Research.

[16]  Yuling Chen,et al.  Berberine Improves Behavioral and Cognitive Deficits in a Mouse Model of Alzheimer's Disease via Regulation of β-Amyloid Production and Endoplasmic Reticulum Stress. , 2021, ACS chemical neuroscience.

[17]  Guowei Yin,et al.  Procyanidine resists the fibril formation of human islet amyloid polypeptide. , 2021, International journal of biological macromolecules.

[18]  Linhua Zhao,et al.  In silico network pharmacology and in vivo analysis of berberine-related mechanisms against type 2 diabetes mellitus and its complications. , 2021, Journal of ethnopharmacology.

[19]  Ying Chen,et al.  Berberine Improves Cognitive Impairment by Simultaneously Impacting Cerebral Blood Flow and β-Amyloid Accumulation in an APP/tau/PS1 Mouse Model of Alzheimer’s Disease , 2021, Cells.

[20]  Zhaohui Fang,et al.  Effect of berberine on hyperglycaemia and gut microbiota composition in type 2 diabetic Goto-Kakizaki rats , 2021, World journal of gastroenterology.

[21]  M. Sassek,et al.  Resveratrol Affects Insulin Signaling in Type 2 Diabetic Goto-Kakizaki Rats , 2021, International journal of molecular sciences.

[22]  Peng Zeng,et al.  [Network pharmacology-based study of the therapeutic mechanism of resveratrol for Alzheimer's disease]. , 2021, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[23]  B. Alghamdi,et al.  Effects of melatonin and resveratrol on recognition memory and passive avoidance performance in a mouse model of Alzheimer’s disease , 2021, Behavioural Brain Research.

[24]  Kiran Kumar Eepuri,et al.  Antidiabetic Effects of Gegen Qinlian Decoction via the Gut Microbiota Are Attributable to Its Key Ingredient Berberine , 2020, Genom. Proteom. Bioinform..

[25]  Chris Lynch,et al.  World Alzheimer Report 2019: Attitudes to dementia, a global survey , 2020 .

[26]  Changyin Yu,et al.  Signaling mechanisms underlying inhibition of neuroinflammation by resveratrol in neurodegenerative diseases. , 2020, The Journal of nutritional biochemistry.

[27]  Junhua Li,et al.  Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study) , 2020, Nature Communications.

[28]  J. Plochocki,et al.  Neuroprotective Effects of Chronic Resveratrol Treatment and Exercise Training in the 3xTg-AD Mouse Model of Alzheimer’s Disease , 2020, International journal of molecular sciences.

[29]  Lijing Yan,et al.  Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[30]  Lina Song,et al.  Berberine attenuates Aβ-induced neuronal damage through regulating miR-188/NOS1 in Alzheimer’s disease , 2020, Molecular and Cellular Biochemistry.

[31]  Jie Liu,et al.  Dendrobium nobile Lindl Alkaloids Ameliorate Cognitive Dysfunction in Senescence Accelerated SAMP8 Mice by Decreasing Amyloid-β Aggregation and Enhancing Autophagy Activity. , 2020, Journal of Alzheimer's disease : JAD.

[32]  Jie Liu,et al.  Dendrobium nobile Lindl alkaloid and metformin ameliorate cognitive dysfunction in senescence-accelerated mice via suppression of endoplasmic reticulum stress , 2020, Brain Research.

[33]  N. Zhang,et al.  Berberine attenuates Aβ42-induced neuronal damage through regulating circHDAC9/miR-142-5p axis in human neuronal cells. , 2020, Life sciences.

[34]  Dandan Huang,et al.  A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[35]  Hayato Akimoto,et al.  Antidiabetic Drugs for the Risk of Alzheimer Disease in Patients With Type 2 DM Using FAERS , 2020, American journal of Alzheimer's disease and other dementias.

[36]  Chun Liu,et al.  The Combined Therapy of Berberine Treatment with lncRNA BACE1-AS Depletion Attenuates Aβ25–35 Induced Neuronal Injury Through Regulating the Expression of miR-132-3p in Neuronal Cells , 2020, Neurochemical Research.

[37]  X. Gu,et al.  Protective effects of grape seed procyanidin on isoflurane-induced cognitive impairment in mice , 2020, Pharmaceutical biology.

[38]  Qin Wu,et al.  Dendrobium alkaloids decrease Aβ by regulating α- and β-secretases in hippocampal neurons of SD rats , 2019, PeerJ.

[39]  Jian Ding,et al.  Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression , 2019, Cell Research.

[40]  Lifang Feng,et al.  Resveratrol Suppresses Aβ-Induced Microglial Activation Through the TXNIP/TRX/NLRP3 Signaling Pathway. , 2019, DNA and cell biology.

[41]  F. Guan,et al.  Amorphous solid dispersion of Berberine mitigates apoptosis via iPLA2β/Cardiolipin/Opa1 pathway in db/db mice and in Palmitate-treated MIN6 β-cells , 2019, International journal of biological sciences.

[42]  Z. Cai,et al.  Berberine Alleviates Amyloid-beta Pathogenesis Via Activating LKB1/AMPK Signaling in the Brain of APP/PS1 Transgenic Mice. , 2019, Current molecular medicine.

[43]  Z. Yao,et al.  Berberine alleviates hyperglycemia by targeting hepatic glucokinase in diabetic db/db mice , 2019, Scientific Reports.

[44]  Jingshan Shi,et al.  Procyanidin protects against 6-hydroxydopamine-induced dopaminergic neuron damage via the regulation of the PI3K/Akt signalling pathway. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[45]  Shuang Rong,et al.  Procyanidins and Alzheimer’s Disease , 2019, Molecular Neurobiology.

[46]  Xu Wang,et al.  Berberine Alleviates Tau Hyperphosphorylation and Axonopathy-Associated with Diabetic Encephalopathy via Restoring PI3K/Akt/GSK3β Pathway. , 2018, Journal of Alzheimer's disease : JAD.

[47]  A. Buzoianu,et al.  Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders , 2018, Front. Pharmacol..

[48]  M. Yokoyama,et al.  Resveratrol-loaded nanoemulsion prevents cognitive decline after abdominal surgery in aged rats. , 2018, Journal of pharmacological sciences.

[49]  J Zhang,et al.  The cost of Alzheimer's disease in China and re-estimation of costs worldwide , 2018, Alzheimer's & Dementia.

[50]  Fei-fei Yan,et al.  Diabetes mellitus and Alzheimer’s disease: GSK-3β as a potential link , 2018, Behavioural Brain Research.

[51]  Hany E. A. Ahmed,et al.  Neuroprotective effect of berberine against environmental heavy metals-induced neurotoxicity and Alzheimer's-like disease in rats. , 2018, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[52]  Z. Cai,et al.  Berberine attenuates cognitive impairment and ameliorates tau hyperphosphorylation by limiting the self-perpetuating pathogenic cycle between NF-κB signaling, oxidative stress and neuroinflammation , 2017, Pharmacological reports : PR.

[53]  Wei Zhang,et al.  Protective effects of Dendrobium nobile Lindl. alkaloids on amyloid beta (25–35)-induced neuronal injury , 2017, Neural regeneration research.

[54]  Xuedong Zhou,et al.  [Berberine regulates type 2 diabetes mellitus related with insulin resistance]. , 2017, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[55]  B. Xie,et al.  Attenuated mTOR Signaling and Enhanced Glucose Homeostasis by Dietary Supplementation with Lotus Seedpod Oligomeric Procyanidins in Streptozotocin (STZ)-Induced Diabetic Mice. , 2017, Journal of agricultural and food chemistry.

[56]  Xin Jiang,et al.  Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease , 2017, Experimental Gerontology.

[57]  Yuanfu Lu,et al.  Dendrobium nobile Lindl alkaloid, a novel autophagy inducer, protects against axonal degeneration induced by Aβ25‐35 in hippocampus neurons in vitro , 2017, CNS neuroscience & therapeutics.

[58]  R. Gambino,et al.  Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial , 2017, Acta Diabetologica.

[59]  M. G. Savelieff,et al.  Towards an understanding of amyloid-β oligomers: characterization, toxicity mechanisms, and inhibitors. , 2017, Chemical Society reviews.

[60]  M. Goodarzi,et al.  Resveratrol Attenuates Copper and Zinc Homeostasis and Ameliorates Oxidative Stress in Type 2 Diabetic Rats , 2017, Biological Trace Element Research.

[61]  Raymond Scott Turner,et al.  Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease , 2017, Journal of Neuroinflammation.

[62]  Yong Tian,et al.  Dendrobium alkaloids prevent Aβ25–35-induced neuronal and synaptic loss via promoting neurotrophic factors expression in mice , 2016, PeerJ.

[63]  Hiroki Sato,et al.  Oral Administration of Apple Procyanidins Ameliorates Insulin Resistance via Suppression of Pro-Inflammatory Cytokine Expression in Liver of Diabetic ob/ob Mice. , 2016, Journal of agricultural and food chemistry.

[64]  G. Münch,et al.  Neuroprotection of Neuro2a cells and the cytokine suppressive and anti-inflammatory mode of action of resveratrol in activated RAW264.7 macrophages and C8–B4 microglia , 2016, Neurochemistry International.

[65]  A. Marette,et al.  Age‐dependent impairment of glucose tolerance in the 3xTg‐AD mouse model of Alzheimer's disease , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[66]  T. Sin,et al.  Modulation of SIRT1-Foxo1 Signaling axis by Resveratrol: Implications in Skeletal Muscle Aging and Insulin Resistance , 2015, Cellular Physiology and Biochemistry.

[67]  M. Pinent,et al.  Procyanidins and their healthy protective effects against type 2 diabetes. , 2014, Current medicinal chemistry.

[68]  J. Drewe,et al.  Antidiabetic effects of the Cimicifuga racemosa extract Ze 450 in vitro and in vivo in ob/ob mice. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[69]  K. Myburgh,et al.  Proanthocyanidins, anthocyanins and cardiovascular diseases , 2014 .

[70]  Yawei Xu,et al.  Resveratrol ameliorates diabetic vascular inflammation and macrophage infiltration in db/db mice by inhibiting the NF-κB pathway , 2014, Diabetes & vascular disease research.

[71]  Jie Dong,et al.  Protective effects of chronic resveratrol treatment on vascular inflammatory injury in streptozotocin-induced type 2 diabetic rats: Role of NF-kappa B signaling. , 2013, European journal of pharmacology.

[72]  Wei-Jia Kong,et al.  Tetrandrine potentiates the hypoglycemic efficacy of berberine by inhibiting P-glycoprotein function. , 2013, Biological & pharmaceutical bulletin.

[73]  H. Soininen,et al.  History of Medically Treated Diabetes and Risk of Alzheimer Disease in a Nationwide Case-Control Study , 2013, Diabetes Care.

[74]  B. Xie,et al.  Oligomeric procyanidins of lotus seedpod inhibits the formation of advanced glycation end-products by scavenging reactive carbonyls. , 2013, Food chemistry.

[75]  Jie Dong,et al.  Protective effects of chronic resveratrol treatment on vascular inflammatory injury in steptozotocin-induced type 2 diabetic rats: role of NF-kappa B signaling. , 2013, European journal of pharmacology.

[76]  P. Carrupt,et al.  HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs? , 2013, Molecular Neurodegeneration.

[77]  Kaixian Chen,et al.  Diverse mechanisms of antidiabetic effects of the different procyanidin oligomer types of two different cinnamon species on db/db mice. , 2012, Journal of agricultural and food chemistry.

[78]  J. Bhatt,et al.  Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. , 2012, Nutrition research.

[79]  T. Mennini.  Resveratrol supplementation , 2012 .

[80]  P. Davies,et al.  Resveratrol mitigates lipopolysaccharide‐ and Aβ‐mediated microglial inflammation by inhibiting the TLR4/NF‐κB/STAT signaling cascade , 2012, Journal of neurochemistry.

[81]  C. Park,et al.  Anti-aging effects of oligomeric proanthocyanidins isolated from persimmon fruits. , 2011, Drug discoveries & therapeutics.

[82]  Caiguo Huang,et al.  Hypoglycemic activities of A- and B-type procyanidin oligomer-rich extracts from different Cinnamon barks. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[83]  T. Szkudelski,et al.  Anti‐diabetic effects of resveratrol , 2011, Annals of the New York Academy of Sciences.

[84]  Lois E. H. Smith,et al.  SIRT1 Is Essential for Normal Cognitive Function and Synaptic Plasticity , 2010, The Journal of Neuroscience.

[85]  Juei-Tang Cheng,et al.  Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats. , 2007, Life sciences.

[86]  L. Mucke,et al.  SIRT1 Protects against Microglia-dependent Amyloid-β Toxicity through Inhibiting NF-κB Signaling* , 2005, Journal of Biological Chemistry.

[87]  J. Wands,et al.  Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes? , 2005, Journal of Alzheimer's disease : JAD.

[88]  L. Mucke,et al.  SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. , 2005, The Journal of biological chemistry.